NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the agreement, NAMSA will take ownership of WuXi’s facilities in Minnesota and Georgia.

BEIJING (AP) -- China has executed two men who committed deadly attacks that killed dozens in November and raised concerns about a surge in what are called "revenge on society crimes," state media ...

Also in November, 21-year-old Xu Jiajin killed eight people and injured 17 others in a stabbing attack at his vocational school in the eastern city of Wuxi. Police said Wu had failed his ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. The deal includes facilities in ...

WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released lower-than ...

Legislation would have cut Chinese businesses off from US WuXi executives say the companies continue to sign new clients WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from ...

WuXi AppTec’s leadership played down concerns about reduced demand for glucagon-like peptide-1 receptor agonist (GLP-1RA) manufacturing after leading obesity player Eli Lilly released ...

At the recent JP Morgan Healthcare Conference 2025, WuXi Biologics’ CEO Chris Chen said the company continues to sign foreign clients and investing in the US, despite political headwinds related to ...

(Yicai) Jan. 14 -- WuXi AppTec’s shares rose after the pharmaceutical services provider sold stakes in an affiliated company, pocketing HKD2.4 billion (USD312 million) after transaction costs. It is ...